Inhibrx Biosciences (INBX)
Develops biologic drug candidates led by ozekibart and INBRX-106.
$101.43
vs last close−9.24 (−8.35%)
Something off on this page? Send us feedback.
Dividend yield
—
Next ex-date
—
Annual dividend
—
Schedule
—
One payment since May 2024
| Ex-date | Record | Paid | Amount | Note |
|---|---|---|---|---|
| May 30, 2024 | May 30, 2024 | Jun 20, 2024 | $0.85 | special dividend |